Hovione Farmaciencia Sa, based in Portugal, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MOMETASONE FUROATE MONOHYDRATE INHALATION GRADE, with a corresponding US DMF Number 25987.
Remarkably, this DMF maintains an Active status since its submission on April 23, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 07, 2017, and payment made on October 14, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II